Leap Therapeutics is developing novel cancer drugs

FIRST-IN-CLASS ANTIBODIES

Our monoclonal antibodies are designed to target key cellular pathways that enable cancer to grow and proliferate, known as cancer cell signaling, and pathways that help the body’s immune system to identify and treat cancer.

BETTER PATIENT OUTCOMES

Therapies targeting cancer cell signaling and T cells  offer new options for patients with cancer.  We are committed to making a difference in the lives of cancer patients. 

Leap is developing drugs to change the practice of cancer medicine

 
LeapTherapeutics Logo_080718_FullColor-H

47 Thorndike Street, Suite B1-1
Cambridge, MA 
02141 USA
Phone: +1-617-714-0360

If you are interested in business development, e-mail us at bd@leaptx.com

Contact 
Twiter Icon.png

© 2019 Leap Therapeutics, Inc.       All Rights Reserved